CS
BIS icon

Credit Suisse’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Credit Suisse’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-862
Closed -$1.31M – 4203
2013
Q2 		$1.31M Buy
+862
New +$1.37M ﹤0.01% 2592

Other funds holding BIS

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Credit Suisse's BIS Position: Q3 2013 in Review

Credit Suisse sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2013, closing a stake of 862 shares — an estimated $1.31M sold.

Credit Suisse first reported a position in BIS in Q2 2013 and held it in 1 quarter. The position peaked at $1.31M in Q2 2013. 2 funds tracked by Wall St. Rank hold BIS as of Q3 2013.

  • Credit Suisse reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2013 after selling out during the quarter.
  • Credit Suisse sold 862 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2013, an estimated $1.31M.
  • Credit Suisse first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and held it in 1 quarter.
  • Credit Suisse's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.31M in Q2 2013.
  • 2 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2013.

Based on Credit Suisse's 13F filing for Q3 2013, filed 13 Nov 2013.